Evidence map›Paper›PMID 25521586›Full record

ArticlePLoS genetics2014

Genetic basis of haloperidol resistance in Saccharomyces cerevisiae is complex and dose dependent.

Xin Wang, Leonid Kruglyak

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xin WangDepartment of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, United States of America.
Leonid KruglyakDepartment of Human Genetics, University of California, Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, California, United States of America; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
Howard Hughes Medical Institute · USPrinceton University · US

Funding

Toward comprehensive genetic dissection of complex traits in yeastR01GM102308 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEONID KRUGLYAK · 2012 to 2026
$3.3M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM102308
6 · The paper itself

Abstract

The genetic basis of most heritable traits is complex. Inhibitory compounds and their effects in model organisms have been used in many studies to gain insights into the genetic architecture underlying quantitative traits. However, the differential effect of compound concentration has not been studied in detail. In this study, we used a large segregant panel from a cross between two genetically divergent yeast strains, BY4724 (a laboratory strain) and RM11_1a (a vineyard strain), to study the genetic basis of variation in response to different doses of a drug. Linkage analysis revealed that the genetic architecture of resistance to the small-molecule therapeutic drug haloperidol is highly dose-dependent. Some of the loci identified had effects only at low doses of haloperidol, while other loci had effects primarily at higher concentrations of the drug. We show that a major QTL affecting resistance across all concentrations of haloperidol is caused by polymorphisms in SWH1, a homologue of human oxysterol binding protein. We identify a complex set of interactions among the alleles of the genes SWH1, MKT1, and IRA2 that are most pronounced at a haloperidol dose of 200 µM and are only observed when the remainder of the genome is of the RM background. Our results provide further insight into the genetic basis of drug resistance.

Indexed as

Antifungal AgentsCarrier ProteinsDose-Response Relationship, DrugDrug Resistance, FungalGTPase-Activating ProteinsHaloperidolHydrogen-Ion ConcentrationMicrobial Sensitivity TestsPolymorphism, GeneticQuantitative Trait LociSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAntifungal AgentsCarrier ProteinsGTPase-Activating ProteinsHaloperidolIRA2 protein, S cerevisiaeMKT1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSWH1 protein, S cerevisiae

Identifiers

PMID25521586
PMCPMC4270474
OpenAlexW2011936684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.